| Date | Target |
Transaction Type Value: $mlns |
Acquirer | Seller | ||
|---|---|---|---|---|---|---|
| 2000-03-01 |
AquaBounty
Life Science Harvard, Massachusetts www.aquabounty.com AquaBounty is a biotechnology company utilizing modern molecular biology to improve aquaculture productivity in a safe and environmentally sustainable manner. AquaBounty was founded in 1991 and is based in Harvard, Massachusetts. |
Venture |
Bay City Capital
|
- | ||
| 2000-11-01 |
Panomics
Life Science Fremont, California www.panomics.com Panomics, Inc. is a privately-held life science tools company with hundreds of commercial products primarily in the fields of transcription regulation, cell signaling and signal transduction. |
Venture |
Bay City Capital
|
- | ||
| 2000-06-01 |
NeurogesX, Inc.
Life Science San Mateo, California www.neurogesx.com NeurogesX, Inc. is a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs and improve patients' quality of life. NeurogesX was founded in 1998 and is based in San Mateo, California. |
Venture |
Montreux Equity Partners
|
- | ||
| 2000-01-01 |
Hypnion, Inc.
Life Science Lexington, Massachusetts www.hypnion.com Hypnion is a biotech company that researches and develops sleep disorder therapies. The company was set up in 2000 by a number of authoritative names in the field of sleep disorder research. It owns the rights to SCORE- 2004™, a method for testing drugs used to treat sleep and waking disorders, which allows quick and accurate measurement of the impact of a particular drug on a broad range of sleep and waking parameters. |
Venture |
GIMV
|
- | ||
| 2000-01-01 |
Arrow Therapeutics Ltd.
Life Science London, United Kingdom www.arrowt.co.uk Arrow Therapeutics utilizes its genome-based target discovery technology to search for novel anti-microbial compounds. The Company is focused on unexplored targets for antibiotics, anti-viral, and anti-fungal therapies and aims to overcome the rapidly growing problem of microbial resistance. |
Venture |
Alta Partners
|
- | ||
| 2000-11-01 |
AquaGene, Inc.
Life Science Alachua, Florida AquaGene has developed proprietary technologies to manufacture biologically active, therapeutic proteins in genetically engineered, or transgenic, fish. A transgenic organism is created by introducing a foreign gene into the organism's genome using a variety of recombinant DNA techniques. The new gene, which provides instructions to make a specific protein, will be passed on to the organism's offspring. The company's strategy is to manufacture and market, in partnership with suitable pharmaceutical companies, proteins with significant commercial potential for either human or veterinary medical applications. The company's first product is human Factor VII, a blood-clotting protein used to treat hemophilia. |
Venture |
Advantage Capital Partners
|
- | ||
| 2000-02-01 |
Syrrx, Inc.
Life Science San Diego, California www.syrrx.com Syrrx, Inc. is a structural genomics company. |
Venture |
Bay City Capital
|
- | ||
| 2000-11-27 |
Cytokinetics
Life Science South San Francisco, California www.cytokinetics.com Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Cytokinetics was founded in 1997 and is headquartered in South San Francisco, California. |
Venture |
Alta Partners
|
- | ||
| 2000-02-01 |
Cymabay Therapeutics
Life Science Newark, California www.cymabay.com Cymabay Therapeutics is a clinical-stage bio-pharmaceutical company developing breakthrough therapies addressing unmet medical needs. Cymabay Therapeutics was founded in 1988 and is based in Newark, California. |
Venture |
Alta Partners
Bay City Capital
Nexus Life Science Partners
|
- | ||
| 2000-04-17 |
Nereus Pharmaceuticals, Inc.
Life Science San Diego, California www.nereuspharm.com Nereus Pharmaceuticals is a pioneer in the use of marine microbial sources for the discovery and follow-on development of new therapeutics for cancer and inflammatory and infectious diseases. |
Venture |
Alta Partners
|
- | ||
| Avg |
$0.0
0.0x EBITDA 0.0x REVENUE |
|||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.
Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.
The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.
